Have you ever wondered how scientists create new medicines, make plants resistant to pests, or even use tiny living things to clean up pollution? All these amazing feats fall under a fascinating field ...

During the 25 years of its existence, the biotechnology industry has grown from a mere handful of ventures into a formidable industry of roughly 1,400 companies in the US and nearly 500 in Europe 1,2.

What if you could bite into a lemon and taste lemonade, without consuming any sugar? What if you could eat a steak without the moral and environmental considerations of slaughtering an animal? These ...

A*STAR scientists have developed a new method to directly and efficiently read DNA containing non-standard “letters” (bases) ...

There can be no doubt any longer that phosphorothioates, the major antisense oligonucleotide in clinical trials and in use in countless laboratories, induce significant non-sequence-specific effects ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and efficiently read DNA containing non-standard bases—a task once thought too ...

Delivering the inaugural address at the Second Foundation Day Celebration of “Biotechnology Research & Innovation Council” ...

The first of his worries is the notion of introducing heritable mutations into the human genome. He Jianqui did this to three human female embryos in China in 2018, so the three girls with the ...

Biotech stocks specialize in companies using living organisms to innovate in disease treatment. Invest in biotechs with diverse drug pipelines and current market products to reduce investment risk.

Mr. Farag added, “Akari is at the forefront of developing a new class of ADCs designed to disrupt cancer cell survival ...